PITTSBURGH--(BUSINESS WIRE)--Helomics® Corporation, a privately-held personalized healthcare company that provides comprehensive tumor profiling products and services based on both live and fixed cell assays, announced today that the Company is a finalist in the Pittsburgh Technology Council’s annual Tech 50 Awards. Helomics was selected as a finalist in the Innovator of the Year – Life Sciences category. The Pittsburgh Technology Council’s annual Tech 50 Awards recognizes southwestern Pennsylv
| < Prev | Next > |
|---|
